The presenting author must register for the full conference at the latest 14 days after acceptance of an abstract.
HERNIA2023 reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration at the latest 14 days after notification on acceptance.
Generic names must be used for all references to products or companies. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. The Scientific Committee reserves the right to replace any brand name with a generic name without further notice.
The body of the abstract must be concise with a maximum of 250 words. The abstract system will not accept abstracts that exceed this limit.
The title should be as brief as possible but long enough to clearly indicate the nature of the study.
No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when submitting your abstract online.
The abstract must include the following:
C/ Marià Cubí, 4 - Pral | 08006 Barcelona
Tel. +34 932.388.777 | Fax: +34 932.387.488
Registration & Accomodation: